Stefano Gambera
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate.
Journal: Nature communications
Published: June 07, 2023
Systemic cellular viroimmunotherapy for canine high-grade gliomas.
Journal: Journal for immunotherapy of cancer
Published: October 19, 2022
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing.
Journal: Cancer research communications
Published: September 13, 2022
RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models.
Journal: Cancers
Published: February 24, 2021
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
Journal: Journal for immunotherapy of cancer
Published: December 26, 2020
c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells.
Journal: Scientific reports
Published: January 22, 2018
Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells.
Journal: Stem cells (Dayton, Ohio)
Published: January 11, 2018
Clonal dynamics in osteosarcoma defined by RGB marking.
Journal: Nature communications
Published: November 26, 2017
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Journal: Cancer immunology, immunotherapy : CII
Published: September 28, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026